Pediatric Drugs

Papers
(The TQCC of Pediatric Drugs is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Diagnosis of Serious Conditions Delayed in Association with Ondansetron Treatment for Vomiting in the Pediatric Emergency Department77
Pharmacogenetic Aspects of Drug Metabolizing Enzymes and Transporters in Pediatric Medicine: Study Progress, Clinical Practice and Future Perspectives66
Alirocumab: Pediatric First Approval56
Treatment Options for Alopecia Areata in Children and Adolescents55
Gentamicin Pharmacokinetics in Neonates Undergoing Therapeutic Hypothermia for Hypoxic Ischemic Encephalopathy53
Acknowledgement to Referees51
Puzolcabtagene Autoleucel: Pediatric First Approval38
Optimizing Drug Selection in Children with Multiple Sclerosis: What Do We Know and What Remains Unanswered?35
Perioperative Indications for Gabapentinoids in Pediatrics: A Narrative Review27
Guselkumab: Pediatric First Approval26
Managing Lupus Nephritis in Children and Adolescents25
Recent Advances in the Management of Seizures in Children24
Prevalence and Temporal Trends of Attention Deficit Hyperactivity Disorder Medication Fills During Pregnancy and Breastfeeding in Denmark24
History and Current Status of Growth Hormone Treatment in Children23
Commercial Versus Compounded Preparations in Pediatric Ophthalmology22
Vedolizumab Versus Other Biologics and the Risk of Venous Thromboembolism in Patients with Pediatric-Onset Inflammatory Bowel Diseases: A Target Trial Emulation Study21
Acute Phase Reaction After First Neridronate Infusion in Children with Osteogenesis Imperfecta: An Analysis Based on Questionnaire Data from 65 Patients20
Intranasal Analgesia in Preterm and Term Neonates19
A New Perspective on Drugs for Duchenne Muscular Dystrophy: Proposals for Better Respiratory Outcomes and Improved Regulatory Pathways19
New Information on Old Medicinal Products: A Cross-Sectional Analysis of Guidance for Paediatric Use for Substances on the European Priority List of Off-Patent Medicinal Products18
Safety and Effectiveness of Pain Medications for Migraine Management During Pregnancy and Lactation18
Ewing Sarcoma Drug Therapy: Current Standard of Care and Emerging Agents17
Real-World Data on the Use of Sirolimus in Asian Children with Vascular Malformations17
Authors’ Reply to Fatima Comment on “Cardioprotective Effect of Nigella sativa in Pediatric Patients with Type 1 Diabetes Mellitus: A Randomized Controlled Study”17
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management16
Improving Methylphenidate Titration in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): A Randomized Controlled Trial Using Placebo-Controlled Titration Implemented in Clinical Practice16
Impact of β-Blockers on the Risk of Low-Birth-Weight Infants in Women with Long QT Syndrome or Marfan Syndrome: A Single-Center Retrospective Study from 2008 to 2022 in a Tertiary Care Center16
Low-Dose Remifentanil in Preterm Cesarean Section with General Anesthesia: A Randomized Controlled Trial15
Pharmacokinetics and Safety of Endotracheal Lidocaine for Endotracheal Intubation in Critically Ill Children15
Pediatric Treatment-Resistant Obsessive Compulsive Disorder: Treatment Options and Challenges15
Learning-Based Models for Predicting IVIG Resistance and Coronary Artery Lesions in Kawasaki Disease: A Review of Technical Aspects and Study Features15
Letermovir for Prophylaxis and Pre-emptive Therapy of Cytomegalovirus Infection in Paediatric Allogeneic Haematopoietic Cell Transplant Patients15
Recent Developments in the Treatment of Pediatric Distal Renal Tubular Acidosis15
Inotuzumab Ozogamicin: First Pediatric Approval15
Dose Rationale of Nasal Glucagon in Japanese Pediatric Patients with Diabetes Using Pharmacokinetic/Pharmacodynamic Modeling and Simulation14
Diagnosis and Management of Non-Infectious Uveitis in Pediatric Patients14
Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children: Rationale and Progress to Date14
Oral Ibuprofen for the Treatment of PDA in Preterm Neonates: Urgent Need for a Safer Alternative to Hyperosmolar Formulations13
Doxecitine and Doxribtimine: First Approval13
Current Treatment Modalities for Urea Cycle Disorders13
Long-Term Safety of Anti-Interleukin-1 Medications in Children with Rheumatic Diseases: a Systematic Review13
Antipsychotic Medications for Delirium Treatment in the Pediatric Intensive Care Unit: A Systematic Review13
Impact of the Time to Initiation of Indomethacin or Ibuprofen on Patent Ductus Arteriosus Closure Rates12
Toward Optimal Treatment Outcomes in New-Onset Polyarticular-Course Juvenile Idiopathic Arthritis12
Levetiracetam Versus Fosphenytoin Infusions as Second-Line Treatment for Pediatric Status Epilepticus: A Multicenter Study Examining Effectiveness, Tolerability, and Ease of Use12
Off-Label Use of Anakinra in Inflammatory Conditions in Neonates and Infants Up to 3 Months of Age: A Case Series and a Review of the Literature12
Emerging Treatments in Neonatal Fungal Infections: Progress and Prospects12
An Update of Pharmacological Management in Children with Functional Constipation12
Targeted Treatments for Myasthenia Gravis in Children and Adolescents12
Optimizing Antifungal Therapy for Pediatric Tinea Capitis: A Narrative Review of Species-Specific Efficacy, Dosing Strategies, and Clinical Implications11
Adverse Event Profile of First-line Drugs for Treating Patent Ductus Arteriosus in Neonates: A Disproportionality Analysis Study of USFDA Adverse Event Reporting System11
Population Pharmacokinetics and Dose Optimization of Piperacillin in Infants and Children with Pneumonia11
Emerging Treatments for Childhood Interstitial Lung Disease10
Treatment of Langerhans Cell Histiocytosis and Histiocytic Disorders: A Focus on MAPK Pathway Inhibitors10
Toxicity Spectrum of Anti-GD2 Immunotherapy: A Real-World Study Leveraging the US Food and Drug Administration Adverse Event Reporting System10
Mechanistic Links Between Obesity and Airway Pathobiology Inform Therapies for Obesity-Related Asthma10
Comparison of Deep and Moderate Neuromuscular Blockade for Major Laparoscopic Surgery in Children: A Randomized Controlled Trial10
Fixed Dosing of Leuprolide Acetate, a GnRH Agonist, in Children with Central Precocious Puberty: A Population Pharmacokinetic Justification9
Effectiveness and Safety of Ustekinumab in Pediatric Ulcerative Colitis: A Multi-center Retrospective Study from the Pediatric IBD Porto Group of ESPGHAN9
Correction: European Society for Developmental Perinatal and Paediatric Pharmacology Congress, June 25 – 27, 2025, Nijmegen, The Netherlands9
Adverse Drug Reactions in Children with Congenital Heart Disease: A Scoping Review9
Effective Sirolimus Use in Prenatal and Postnatal Management of Symptomatic Extensive Congenital Capillary-Lymphatic-Venous Malformations (CLVMs): A Report of Two Cases9
Prescription Trends for Primary Headache in Children and Adolescents in China During 2019–2023: A Retrospective Study9
Dual-Targeted Therapy in Pediatric Inflammatory Bowel Disease: A Comprehensive Review9
Dosing and Discontinuation of Methylphenidate Medication in Relation to Weight Status in Children and Adolescents9
Neuroimaging as a Tool for Advancing Pediatric Psychopharmacology9
Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy: A Systematic Review9
0.75672698020935